2020
DOI: 10.21203/rs.3.rs-83772/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Fair allocation of potential COVID-19 vaccines using an optimization-based strategy

Abstract: The fair allocation of resources among multiple stakeholders in any area is a complex challenge for decision-making. This paper presents an optimization strategy for the allocation of COVID-19 vaccines, when they are available, through different fairness schemes (social welfare, Nash, Rawlsian justice, and social welfare II scheme). The applicability of the proposed model is illustrated using the case study of Mexico, including the states of the country as stakeholders. We involve several parameters to guide t… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 17 publications
0
8
0
Order By: Relevance
“…Countries worldwide faced the greatest challenge last year brought by the coronavirus disease 2019 (COVID-19) pandemic, and the need for a vaccine has become more important than ever [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] . The fair allocation of COVID-19 vaccine distribution is encouraged by the World Health Organisation, and public health benefits must be maximized in order that health products are available and accessible to those in need [83] . However, the distribution mechanism of COVID-19 vaccine doses considered a MCDM problem because of the following issues: required inclusion of different distribution criteria, criteria that are different in significance and increase in problem complexity because of data variation amongst the included criteria.…”
Section: Methodsmentioning
confidence: 99%
“…Countries worldwide faced the greatest challenge last year brought by the coronavirus disease 2019 (COVID-19) pandemic, and the need for a vaccine has become more important than ever [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] . The fair allocation of COVID-19 vaccine distribution is encouraged by the World Health Organisation, and public health benefits must be maximized in order that health products are available and accessible to those in need [83] . However, the distribution mechanism of COVID-19 vaccine doses considered a MCDM problem because of the following issues: required inclusion of different distribution criteria, criteria that are different in significance and increase in problem complexity because of data variation amongst the included criteria.…”
Section: Methodsmentioning
confidence: 99%
“…Recently, Munguía-López and Ponce-Ortega ( 2021 ) developed a strategy for the distribution of vaccines that implements the use of distribution schemes based on the theories of justice of Social Welfare, Rawls, and Nash. With these schemes, it is intended to reach an optimal and fair solution through the evaluation of parameters related to the medical area, such as the sectors of the population affected by autoimmune diseases or the elderly (population with higher epidemiological risk).…”
Section: Models and Strategiesmentioning
confidence: 99%
“…However, under the condition of the highly infectious characteristics of SARS-CoV-2, an immunisation strategy based on reducing transmission has not been highly valued by scholars, despite it being an indispensable part of reducing the overall burden of disease in previous allocation strategies for influenza vaccines and the RTS,S malaria vaccine [ 20 , 21 ]. Incorporating correlations between the spread of the epidemic in different regions into the model from a spatial dimension to identify health-oriented vaccine allocation strategies is a high priority in the context of the current pandemic [ 22 ]. Therefore, this study used a cross-regional SEIR model that considered the interactions of epidemic evolution in different regions to explore epidemic prevention and control effects that the health-oriented vaccine allocation strategies could produce.…”
Section: Introductionmentioning
confidence: 99%